PRE-MARKET CHINESE STOCK NEWS: Several Hong Kong banks increased mortgage rates and lending rates following the HKMA base rate hike. (Newswires)

CHINA

China Medical & Healthcare (383 HK) – Reports FY 18 revenue HKD 1.1bln vs. Prev. HKD 1.3bln. Net loss HKD 137.1mln vs. Prev. loss HKD 71.8mln. (Newswires)

China Mobile (941 HK) – Chinese antitrust officials are said to be looking into allegations of market dominance by China Mobile. (Newswires)

Yifan Pharma (002019 CH) – Co. entered into an exclusive multi-year, multi-million-dollar collaboration agreement with US listed Amyris

Meituan Dianping (3690 HK) – reports H1 revenue CNY 26.3bln, adj. net -CNY 4.2bln. (Newswires)

OTHER NEWS

– FTSE Russell are said to see USD 2.5tln inflow to the Chinese securities market. (Newswires)

– Several Hong Kong banks increased mortgage rates and lending rates following the HKMA base rate hike. (Newswires)

– Chinese Commerce Ministry spokesperson said China is open to US negotiations to resolve trade issues, while he added extreme US pressure won’t cripple Chinese Economy. (Newswires)

– There were reports many large cap Chinese companies are actively looking for investment opportunities in Turkey. (Newswires)

– Analysts at UBS said Hong Kong has the most overvalued housing market and the greatest risk of a bubble. (SCMP)

(Newswires)